Meeting
2023 ASCO Annual Meeting
Association between excess body mass index trajectory and change in monoclonal protein level in patients diagnosed with monoclonal gammopathy of undetermined significance.
Authors
Lawrence Liu
City of Hope National Comprehensive Cancer Center, Duarte, CA
Lawrence Liu , Nikhil Grandhi , Mei Wang , Theodore Seth Thomas , Akhil Kumar , Kristen Marie Sanfilippo , Graham A. Colditz , Su-Hsin Chang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Cancer Prevention
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10538)
DOI
10.1200/JCO.2023.41.16_suppl.10538
Abstract #
10538
Poster Bd #
171
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Impact of obesity on response in 751 myeloma patients receiving lenalidomide, bortezomib, and dexamethasone (RVd) induction.
First Author: R Donald Harvey
Poster
2017 ASCO Annual Meeting
The impact of body mass index on the risk of early progression of smoldering multiple myeloma to symptomatic myeloma.
First Author: Wilson I. Gonsalves
Poster
2014 ASCO Annual Meeting
Obesity-induced alteration in iron metabolism via elevated hepcidin and the risk of postmenopausal breast cancer among Caucasians.
First Author: Puja Agarwal
Poster
2024 ASCO Annual Meeting
From criteria to clinic: How updated SLiM CRAB criteria influence multiple myeloma diagnostic activity.
First Author: Mengmeng Ji